DekaBank Deutsche Girozentrale
ANAC

DekaBank Deutsche Girozentrale’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,790
Closed -$1.28M – 1111
2016
Q1 		$1.28M Sell
21,790
-600
-3% -$44.3K 0.02% 514
2015
Q4 		$2.51M Buy
22,390
+370
+2% +$40.8K 0.03% 432
2015
Q3 		$2.59M Buy
22,020
+1,120
+5% +$146K 0.03% 421
2015
Q2 		$1.62M Buy
20,900
+800
+4% +$52.5K 0.02% 482
2015
Q1 		$1.16M Sell
20,100
-2,400
-11% -$102K 0.01% 550
2014
Q4 		$701K Sell
22,500
-2,100
-9% -$63K 0.01% 630
2014
Q3 		$602K Buy
24,600
+600
+3% +$12.2K 0.01% 614
2014
Q2 		$426K Sell
24,000
-1,300
-5% -$20.9K 0.01% 634
2014
Q1 		$506K Buy
25,300
+2,200
+10% +$42.7K 0.01% 574
2013
Q4 		$403K Buy
23,100
+600
+3% +$8.3K 0.01% 577
2013
Q3 		$239K Buy
22,500
+1,000
+5% +$8.75K ﹤0.01% 640
2013
Q2 		$119K Buy
+21,500
New +$130K ﹤0.01% 590

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ANAC Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 21,790 shares — an estimated $1.28M sold.

DekaBank Deutsche Girozentrale first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $2.59M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 21,790 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.28M.
  • DekaBank Deutsche Girozentrale first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • DekaBank Deutsche Girozentrale's ANACOR PHARMACEUTICALS INC COM position peaked at $2.59M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.